This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

16 Newly Rated ETFs to Buy

NEW YORK ( TheStreet Ratings) -- TheStreet.com Ratings initiated coverage of 40 exchange-traded funds, or ETFs, that accrued a sufficient track record of risk and performance data by the end of August 2011. 16 of the 40 newly rated exchange-traded funds start out in the 'Buy' range. 11 begin at 'Hold' while 13 earned initial grades in the 'Sell' range.

Three of the newly rated funds that opened for business by August of 2010 received our highest possible rating of A+, or Excellent. Of these, the best performer, iShares MSCI Indonesia Investable Market Index Fund (EIDO), returned 24.4% in the last year.

This emerging market fund seeks investment results that correspond generally to the price and yield performance of the MSCI Indonesia Investable Market Index. The index is designed to measure the performance of equity securities in the top 99% by market capitalization of equity securities listed on stock exchanges in Indonesia.

The other two funds rated at A+ are both Schwab ETFs holding U.S. government debt instruments. Returning 12.2% in a year, the Schwab US TIPS ETF (SCHP) seeks investment results that track the price and yield performance of the Barclays Capital U.S. Treasury Inflation Protected Securities Index. U.S TIPS are securities issued by the U.S. Treasury that generate principal and interest payments designed to adjust for and help protect against inflation.

Schwab Intmdt-Term US Treasury ETF (SCHR) targets investment results that track the price and yield performance of the Barclays Capital U.S. 3-10 Year Treasury Bond Index. The Fund invests in U.S Treasury securities that have a remaining maturity of three to ten years, are rated investment grade, and have $250 million or more of outstanding face value. Returning 7.3% in the last year, this ETF earned the top rating of A+ by avoiding volatility experienced by other funds.

The best newly rated equity ETF, MSCI ACWI ex US Health Care Sector Index Fund (AXHE) gained 16.9% in a year. The fund seeks investment results that correspond generally to the price and yield performance of the MSCI All Country World ex USA Health Care Index. The Underlying Index is designed to measure the combined equity market performance of the health care sector of developed and emerging markets countries excluding the US. Foreign healthcare companies held include Novartis AG (NVS - Get Report), Astrazeneca PLC (AZN - Get Report), and GlaxoSmithKline PLC (GSK - Get Report).

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
SCHR $53.69 0.00%
SCHP $54.87 0.25%
EIDO $27.30 -1.52%
AXHE $0.00 0.00%
AZN $67.79 -0.72%

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs